Clinical Trial Update: A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459) [Phase 3]

View source ↗

Summary

A Phase 3 long-term study of mometasone furoate nasal spray in perennial allergic rhinitis has completed enrollment and status is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• Mometasone furoate (Mometasone furoate)

Snippet

Sponsor: Organon and Co | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED